معرفی
Antonello Mai is a Full Professor in the Department of Pharmaceutical Chemistry and Technology at Sapienza University of Rome's Faculty of Pharmacy and Medicine. He teaches Pharmaceutical and Toxicological Chemistry and leads research on epigenetic modulators for cancer, neurodegenerative disorders, and infectious diseases. His work has yielded 400+ publications and major grants, including a €673,600 FISR project on methylome dysregulation in cancer.
Research interests focus on:
- Epigenetic drug design (HDAC, SIRT, DNMT inhibitors)
- Anticancer mechanisms and drug resistance
- Antiviral/antimicrobial compound development
Recent publications emphasize sirtuin modulators, HDAC inhibitors, and RNA epigenetics, revealing trends toward translational applications in oncology and infection biology.
Honors include:
- Membership in the Italian Chemical Society (since 1992)
- Executive roles in European medicinal chemistry organizations
- ANVUR accreditation for academic quality oversight
He has advised doctoral students as Coordinator of Sapienza's Pharmaceutical Sciences PhD program (2012–2018) and secured NIH/AIRC funding for epigenetic drug discovery. His team explores mitochondrial sirtuins and metastasis pathways.
Antonello Mai در سایتهای دیگر
جستوجوهای مرتبط
شاید اینها هم برایتان مناسب باشند
- RRossella FioravantiSapienza University of Rome · دانشیار
- SSergio ValenteSapienza University of Rome · دانشیار
- MManfred JungAlbert Ludwig University of Freiburg · استاد
Elena CicheroUniversity of Genoa · دانشیار
Viranga TillekeratneUniversity of Toledo · استاد- MMarianna NalliSapienza University of Rome · دانشیار